Conversely, population studies have found no association between increased risk of diabetic retinopathy and GLP-1 RA use [104, 105], with a low odds ratio observed for exenatide (OR 0.16), liraglutide (OR 0.18), albiglutide (OR 0.09), and dulaglutide (OR 0.11) [106]
This review explores the mechanisms, clinical development, and therapeutic potential of these novel agents, excluding already approved drugs like liraglutide, semaglutide, and tirzepatide
Limited RCTs have been published thus far on patient populations with hypertension specifically, with blood pressure variations being measured as a primary endpoint and tracked long-term
low Akkermansia levels are strongly linked to obesity, type 2 diabetes, and metabolic syndrome
Check if your Anthem Blue Cross Blue Shield plan may cover weight loss treatment in Arizona Find the right provider for your needs select your state to find expert care near you.
For targeted gut health support, dedicated compounds covered in our peptides for gut health guide may be more appropriate than relying on retatrutide alone
